收藏切换
Coping strategies for the management of subjects visits in clinical trials of drugs for chronic liver disease during the epidemic of corona virus disease 2019
收藏切换
Lihong XU1, Han LI2, Yuan ZHANG1, Yaping LI1, Shuangsuo DANG1, *
World Clinical Drug | 2022, 43(6) : 799 - 805
Less
收藏切换
World Clinical Drug | 2022, 43(6): 799-805
• Pharmacy administration •
Coping strategies for the management of subjects visits in clinical trials of drugs for chronic liver disease during the epidemic of corona virus disease 2019
Full
Lihong XU1, Han LI2, Yuan ZHANG1, Yaping LI1, Shuangsuo DANG1, *
Affiliations
  • 1.Department of Infectious Disease, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province, China
  • 2.Office of Drug Clinical Trial Institution, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province, China
Published: 2022-06-10 doi: 10.13683/j.wph.2022.06.026
Outline
收藏切换
Objective

To optimize the management of subject visits in clinical trials of drugs for chronic liver disease, meet the requirements of epidemic prevention and control, and reduce the risk of infection during the epidemic of corona virus disease 2019 (COVID-19).

Methods

A total of 103 subjects with chronic liver disease who underwent drug clinical trials in department of infectious disease, the second affiliated hospital of Xi'an Jiaotong university were enrolled from 5 December 2019 to 6 December 2020. Clinical data including gender, age, education level, clinical drug research experience, completion of visit and adverse reactions were analyzed, and the coping strategies of liver disease subjects at this stage were put forward according to the possible influencing factors.

Results

During the epidemic of COVID-19, 1 329 subjects were planned to visit, 1 329 subjects were completed (100%), and 1 318 subjects were returned to the hospital (99.17%). Among them, 2 subjects were visited by out of time visits (0.15%). Eleven subjects were allowed to visit hospitals near their place of residence (0.83%). A total of 47 subjects had adverse reactions (3.54%), and no one infected with COVID-19.

Conclusion

During the prevention and control of the COVID-19 epidemic, classified visit management should be implemented according to the visit plan of drug clinical trials to strengthen the communication and coordination between researchers and subjects, protect the rights and interests of subjects, reduce the risk of COVID-19 infection, and ensure the smooth implementation of the research projects.

corona virus disease 2019  /  liver disease  /  subject  /  visit  /  coping strategy
许丽红, 李涵, 张媛, 李亚萍, 党双锁. 新型冠状病毒肺炎疫情下慢性肝病药物临床试验中受试者访视管理的应对策略. 世界临床药物, 2022 , 43 (6) : 799 -805 . DOI: 10.13683/j.wph.2022.06.026
Lihong XU, Han LI, Yuan ZHANG, Yaping LI, Shuangsuo DANG. Coping strategies for the management of subjects visits in clinical trials of drugs for chronic liver disease during the epidemic of corona virus disease 2019[J]. World Clinical Drug, 2022 , 43 (6) : 799 -805 . DOI: 10.13683/j.wph.2022.06.026
Year 2022 volume 43 Issue 6
10
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.06.026
  • Receive Date:2021-09-25
  • Online Date:2026-11-19
  • Published:2022-06-10
Article Data
Affiliations
History
  • Received:2021-09-25
Funding
Affiliations
    1.Department of Infectious Disease, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province, China
    2.Office of Drug Clinical Trial Institution, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.06.026
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT